Notes to the Financial Statements (continued) for the year ended 30 September 2011


7. Grants awarded (continued) Medical Science Group


University of Cambridge University of Oxford


University College London Imperial College London University of Edinburgh


London School of Hygiene & Tropical Medicine King’s College London University of Dundee


The Institute of Cancer Research University of Manchester


Novartis Institute for Tropical Diseases, Singapore University of Glasgow


Wellcome Trust/Department of Biotechnology India Alliance, India


University of Newcastle Upon Tyne Babraham Institute, UK Diamond Light Source Ltd


European Molecular Biology Laboratory University of Bristol


Medicines for Malaria Venture, Switzerland Medical Research Council Cardiff University University of Leeds


University of Birmingham


Liverpool School of Tropical Medicine London Research Institute University of Sussex University of Leicester


Grants to other organisations


Total grants (excluding supplementations and grants no longer required)


Grant supplementations


Less: grants awarded in previous years no longer required


Grants awarded by the Group of which United Kingdom


Directly funded international Grants awarded by the Group


58.9 57.9 37.9 25.0 22.8 14.6 12.0 11.7 3.1 8.7 —


7.7 6.3


5.2 5.7 5.3 5.3 5.0 5.0 4.8 3.8 4.3 4.2 4.0 4.1 4.0 1.0


40.6


368.9 4.2


(10.1) 363.0


337.1 25.9


363.0


Humanities and


Funding Engagement £m


£m 0.7


3.1 0.5 0.1 0.5 0.5 0.3 — —


0.8 —


0.1 —


— — — — — — — —


0.2 —


0.1 — —


1.2 12.2


20.3 —


—


20.3 19.2 1.1


20.3


Technology Transfer £m


4.9 1.3 4.5 1.5 1.2 2.2 2.3 0.2 6.7 —


8.7 —


—


0.8 — — — — — —


0.9 — — — — —


1.0 17.1


53.3 —


—


53.3 29.1 24.2


53.3


Total 2011 £m


64.5 62.3 42.9 26.6 24.5 17.3 14.6 11.9 9.8 9.5 8.7 7.8


6.3 6.0 5.7 5.3 5.3 5.0 5.0 4.8 4.7 4.5 4.2 4.1 4.1 4.0 3.2


69.9


442.5 4.2


(10.1) 436.6


385.4 51.2


436.6


Total 2010 £m


51.7 79.4 37.9 18.0 28.0 14.4 12.3 26.6 4.1


13.7 0.3 9.8


5.6


11.0 —


5.0 0.4


12.0 —


0.4 7.3 4.6 5.1 2.1 0.6 0.8 3.3


131.4


485.8 4.2


(16.8) 473.2


420.4 52.8


473.2


46 | Annual Report 2011


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80